{
    "summary": "The Small Biotech Innovation Act amends the Social Security Act to exempt research and development-intensive small biotech manufacturers from the Medicare drug price negotiation program. The bill defines a 'research and development-intensive small biotech manufacturer' based on their investment in R&D and the number of qualifying single-source drugs they produce. It outlines application procedures for manufacturers seeking the exemption, including dispute resolution processes, and addresses scenarios where a manufacturer is acquired.",
    "tags": [
        "Healthcare",
        "Healthcare access",
        "Economic stimulus",
        "Consumer protection"
    ],
    "category": "Healthcare & Public Health"
}